Platelet inhibition by insulin is absent in type 2 diabetes mellitus

被引:174
作者
Ferreira, IA
Mocking, AIM
Feijge, MAH
Gorter, G
van Haeften, TW
Heemskerk, JWM
Akkerman, JWN
机构
[1] Univ Utrecht, Med Ctr, Dept Hematol, Lab Thrombosis & Haemostasis, NL-3584 CX Utrecht, Netherlands
[2] Univ Utrecht, Inst Biomembranes, NL-3584 CX Utrecht, Netherlands
[3] Univ Maastricht, Dept Biochem & Huma Biol, Maastricht, Netherlands
[4] Univ Utrecht, Med Ctr, Dept Internal Med, NL-3584 CX Utrecht, Netherlands
关键词
P2y(12) receptor; Ca2+ regulation; clopidogrel; protein kinase B/Akt; IRS-1;
D O I
10.1161/01.ATV.0000199519.37089.a0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective - ADP-induced P2y(12) signaling is crucial for formation and stabilization of an arterial thrombus. We demonstrated recently in platelets from healthy subjects that insulin interferes with Ca2+ increases induced by ADP-P2y(1) contact through blockade of the G-protein G(i), and thereby with P2y(12)-mediated suppression of cAMP. Methods and Results - Here we show in patients with type 2 diabetes mellitus ( DM2) that platelets have lost responsiveness to insulin leading to increased adhesion, aggregation, and procoagulant activity on contact with collagen. Using Ser(473) phosphorylation of protein kinase B as output for insulin signaling, a 2-fold increase is found in insulin-stimulated normal platelets, but in DM platelets there is no significant response. In addition, DM2 platelets show increased P2y(12)-mediated suppression of cAMP and decreased P2y(12) inhibition by the receptor antagonist AR-C69931MX. Conclusion - The loss of responsiveness to insulin together with increased signaling through P2y(12) might explain the hyperactivity of platelets in patients with DM2.
引用
收藏
页码:417 / 422
页数:6
相关论文
共 49 条
  • [1] Phosphopleckstrin inhibits G beta gamma-activable platelet phosphatidylinositol-4,5-bisphosphate 3-kinase
    Abrams, CS
    Zhang, J
    Downes, CP
    Tang, XW
    Zhao, W
    Rittenhouse, SE
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (41) : 25192 - 25197
  • [2] COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS
    ALTMAN, R
    CARRERAS, L
    DIAZ, R
    FIGUEROA, E
    PAOLASSO, E
    PARODI, JC
    CADE, JF
    DONNAN, G
    EADIE, MJ
    GAVAGHAN, TP
    OSULLIVAN, EF
    PARKIN, D
    RENNY, JTG
    SILAGY, C
    VINAZZER, H
    ZEKERT, F
    ADRIAENSEN, H
    BERTRANDHARDY, JM
    BRAN, M
    DAVID, JL
    DRICOT, J
    LAVENNEPARDONGE, E
    LIMET, R
    LOWENTHAL, A
    MORIAU, M
    SCHAPIRA, S
    SMETS, P
    SYMOENS, J
    VERHAEGHE, R
    VERSTRAETE, M
    ATALLAH, A
    BARNETT, H
    BATISTA, R
    BLAKELY, J
    CAIRNS, JA
    COTE, R
    CROUCH, J
    EVANS, G
    FINDLAY, JM
    GENT, M
    LANGLOIS, Y
    LECLERC, J
    NORRIS, J
    PINEO, GF
    POWERS, PJ
    ROBERTS, R
    SCHWARTZ, L
    SICURELLA, J
    TAYLOR, W
    THEROUX, P
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1994, 308 (6921): : 81 - 100
  • [3] P2Y12 regulates platelet adhesion/activation, thrombus growth, and thrombus stability in injured arteries
    André, P
    Delaney, SM
    LaRocca, T
    Vincent, D
    DeGuzman, F
    Jurek, M
    Koller, B
    Phillips, DR
    Conley, PB
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2003, 112 (03) : 398 - 406
  • [4] Thrombopoietin in patients with congenital thrombocytopenia and absent radii: Elevated serum levels, normal receptor expression, but defective reactivity to thrombopoietin
    Ballmaier, M
    Schulze, H
    Strauss, G
    Cherkaoui, K
    Wittner, N
    Lynen, S
    Wolters, S
    Bogenberger, J
    Welte, K
    [J]. BLOOD, 1997, 90 (02) : 612 - 619
  • [5] A common mutation of the insulin receptor substrate-1 gene is a risk factor for coronary artery disease
    Baroni, MG
    D'Andrea, MP
    Montali, A
    Pannitteri, G
    Barillà, F
    Campagna, F
    Mazzei, E
    Lovari, S
    Seccareccia, F
    Campa, PP
    Ricci, G
    Pozzilli, P
    Urbinati, G
    Arca, M
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (12) : 2975 - 2980
  • [6] Diabetes mellitus - A hypercoagulable state
    Carr, ME
    [J]. JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2001, 15 (01) : 44 - 54
  • [7] Colwell John A, 2004, Diabetes Care, V27 Suppl 1, pS72
  • [8] Impaired Ca2+-induced tyrosine phosphorylation and defective lipid scrambling in erythrocytes from a patient with Scott syndrome:: A study using an inhibitor for scramblase that mimics the defect in Scott syndrome
    Dekkers, DWC
    Comfurius, P
    Vuist, WMJ
    Billheimer, JT
    Dicker, I
    Weiss, HJ
    Zwaal, RFA
    Bevers, EM
    [J]. BLOOD, 1998, 91 (06) : 2133 - 2138
  • [9] Development of platelet inhibition by cAMP during megakaryocytopoiesis
    den Dekker, E
    Gorter, G
    Heemskerk, JWM
    Akkerman, JWN
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (32) : 29321 - 29329
  • [10] Cyclic AMP raises intracellular Ca2+ in human megakaryocytes independent of protein kinase A
    den Dekker, E
    Heemskerk, JWM
    Gorter, G
    van der Vuurst, H
    Donath, J
    Kroner, C
    Mikoshiba, K
    Akkerman, JWN
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (01) : 179 - 186